1.
Dasatinib synergizes with JSI-124 to inhibit growth and migration and induce apoptosis of malignant human glioma cells. JOC [Internet]. 2010 Feb. 20 [cited 2025 Dec. 6];9(1). Available from: https://carcinogenesis.com/index.php/JOC/article/view/173